FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1936353033> ?p ?o ?g. }

• W1936353033 abstract "Docosahexaenoic acid (DHA) is a natural compound with anticancer and anti-angiogenesis activity that is currently under investigation as both a preventative agent and an adjuvant to breast cancer therapy. However, the precise mechanisms of DHA’s anticancer activities are unclear. It is understood that the intercommunication between cancer cells and their microenvironment is essential to tumor angiogenesis. Exosomes are extracellular vesicles that are important mediators of intercellular communication and play a role in promoting angiogenesis. However, very little is known about the contribution of breast cancer exosomes to tumor angiogenesis or whether exosomes can mediate DHA’s anticancer action. Exosomes were collected from MCF7 and MDA-MB-231 breast cancer cells after treatment with DHA. We observed an increase in exosome secretion and exosome microRNA contents from the DHA-treated cells. The expression of 83 microRNAs in the MCF7 exosomes was altered by DHA (>2-fold). The most abundant exosome microRNAs (let-7a, miR-23b, miR-27a/b, miR-21, let-7, and miR-320b) are known to have anti-cancer and/or anti-angiogenic activity. These microRNAs were also increased by DHA treatment in the exosomes from other breast cancer lines (MDA-MB-231, ZR751 and BT20), but not in exosomes from normal breast cells (MCF10A). When DHA-treated MCF7 cells were co-cultured with or their exosomes were directly applied to endothelial cell cultures, we observed an increase in the expression of these microRNAs in the endothelial cells. Furthermore, overexpression of miR-23b and miR-320b in endothelial cells decreased the expression of their pro-angiogenic target genes (PLAU, AMOTL1, NRP1 and ETS2) and significantly inhibited tube formation by endothelial cells, suggesting that the microRNAs transferred by exosomes mediate DHA’s anti-angiogenic action. These effects could be reversed by knockdown of the Rab GTPase, Rab27A, which controls exosome release. We conclude that DHA alters breast cancer exosome secretion and microRNA contents, which leads to the inhibition of angiogenesis. Our data demonstrate that breast cancer exosome signaling can be targeted to inhibit tumor angiogenesis and provide new insight into DHA’s anticancer action, further supporting its use in cancer therapy." @default.
• W1936353033 created "2016-06-24" @default.
• W1936353033 creator A5010635408 @default.
• W1936353033 creator A5030347346 @default.
• W1936353033 creator A5039880533 @default.
• W1936353033 creator A5043275768 @default.
• W1936353033 creator A5046942450 @default.
• W1936353033 creator A5073604253 @default.
• W1936353033 date "2015-07-16" @default.
• W1936353033 modified "2023-10-17" @default.
• W1936353033 title "Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA)" @default.
• W1936353033 cites W1573681132 @default.
• W1936353033 cites W1877686344 @default.
• W1936353033 cites W1965691046 @default.
• W1936353033 cites W1968904691 @default.
• W1936353033 cites W1975561204 @default.
• W1936353033 cites W1979751563 @default.
• W1936353033 cites W1991087195 @default.
• W1936353033 cites W1992722664 @default.
• W1936353033 cites W1994343272 @default.
• W1936353033 cites W1998802762 @default.
• W1936353033 cites W2005729354 @default.
• W1936353033 cites W2008775304 @default.
• W1936353033 cites W2012471060 @default.
• W1936353033 cites W2012538473 @default.
• W1936353033 cites W2015717700 @default.
• W1936353033 cites W2017426710 @default.
• W1936353033 cites W2026686857 @default.
• W1936353033 cites W2027461947 @default.
• W1936353033 cites W2032945008 @default.
• W1936353033 cites W2033230987 @default.
• W1936353033 cites W2033859595 @default.
• W1936353033 cites W2035844407 @default.
• W1936353033 cites W2037131199 @default.
• W1936353033 cites W2039687540 @default.
• W1936353033 cites W2058767592 @default.
• W1936353033 cites W2060264900 @default.
• W1936353033 cites W2063508984 @default.
• W1936353033 cites W2064360454 @default.
• W1936353033 cites W2064946335 @default.
• W1936353033 cites W2065019417 @default.
• W1936353033 cites W2067326892 @default.
• W1936353033 cites W2068893166 @default.
• W1936353033 cites W2076918724 @default.
• W1936353033 cites W2084287954 @default.
• W1936353033 cites W2098637032 @default.
• W1936353033 cites W2104678766 @default.
• W1936353033 cites W2109794064 @default.
• W1936353033 cites W2115093090 @default.
• W1936353033 cites W2117394321 @default.
• W1936353033 cites W2118258530 @default.
• W1936353033 cites W2119043140 @default.
• W1936353033 cites W2119764013 @default.
• W1936353033 cites W2146389661 @default.
• W1936353033 cites W2147056998 @default.
• W1936353033 cites W2150395782 @default.
• W1936353033 cites W2168031418 @default.
• W1936353033 cites W2401355890 @default.
• W1936353033 cites W2916083703 @default.
• W1936353033 doi "https://doi.org/10.1186/s12943-015-0400-7" @default.
• W1936353033 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4504101" @default.
• W1936353033 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26178901" @default.
• W1936353033 hasPublicationYear "2015" @default.
• W1936353033 type Work @default.
• W1936353033 sameAs 1936353033 @default.
• W1936353033 citedByCount "171" @default.
• W1936353033 countsByYear W19363530332015 @default.
• W1936353033 countsByYear W19363530332016 @default.
• W1936353033 countsByYear W19363530332017 @default.
• W1936353033 countsByYear W19363530332018 @default.
• W1936353033 countsByYear W19363530332019 @default.
• W1936353033 countsByYear W19363530332020 @default.
• W1936353033 countsByYear W19363530332021 @default.
• W1936353033 countsByYear W19363530332022 @default.
• W1936353033 countsByYear W19363530332023 @default.
• W1936353033 crossrefType "journal-article" @default.
• W1936353033 hasAuthorship W1936353033A5010635408 @default.
• W1936353033 hasAuthorship W1936353033A5030347346 @default.
• W1936353033 hasAuthorship W1936353033A5039880533 @default.
• W1936353033 hasAuthorship W1936353033A5043275768 @default.
• W1936353033 hasAuthorship W1936353033A5046942450 @default.
• W1936353033 hasAuthorship W1936353033A5073604253 @default.
• W1936353033 hasBestOaLocation W19363530331 @default.
• W1936353033 hasConcept C104317684 @default.
• W1936353033 hasConcept C121608353 @default.
• W1936353033 hasConcept C145059251 @default.
• W1936353033 hasConcept C19038510 @default.
• W1936353033 hasConcept C203014093 @default.
• W1936353033 hasConcept C20518536 @default.
• W1936353033 hasConcept C2777171753 @default.
• W1936353033 hasConcept C2780394083 @default.
• W1936353033 hasConcept C2781261824 @default.
• W1936353033 hasConcept C502942594 @default.
• W1936353033 hasConcept C543025807 @default.
• W1936353033 hasConcept C54355233 @default.
• W1936353033 hasConcept C55493867 @default.
• W1936353033 hasConcept C86803240 @default.
• W1936353033 hasConcept C95444343 @default.
• W1936353033 hasConcept C96232424 @default.
• W1936353033 hasConceptScore W1936353033C104317684 @default.

• next